Pharmadrug Inc.
PHRX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.68M | -9.77M | -9.98M | -9.71M | -850.90K |
| Total Depreciation and Amortization | 47.00K | 37.80K | 28.60K | 19.30K | -7.10K |
| Total Amortization of Deferred Charges | 0.00 | 4.40K | 16.50K | 28.40K | 40.10K |
| Total Other Non-Cash Items | 9.05M | 9.03M | 9.04M | 8.95M | 2.08M |
| Change in Net Operating Assets | 13.50K | 19.50K | 265.30K | 420.20K | 204.10K |
| Cash from Operations | -571.60K | -683.00K | -630.20K | -295.10K | 1.98M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 545.10K | 545.10K | 545.10K | 545.10K | -- |
| Divestitures | -- | -- | -- | -- | 400.00 |
| Other Investing Activities | -200.00 | 5.80K | 34.00K | 187.70K | 257.30K |
| Cash from Investing | 544.80K | 550.80K | 579.00K | 732.70K | 257.90K |
| Total Debt Issued | 100.00K | 100.00K | 200.00K | 200.00K | 100.00K |
| Total Debt Repaid | -96.00K | -96.00K | -96.00K | -192.00K | -96.00K |
| Issuance of Common Stock | 326.00K | 326.00K | 326.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 221.50K | 521.50K | 514.70K | 494.20K | 272.70K |
| Cash from Financing | 407.60K | 631.30K | 700.60K | 372.60K | 156.40K |
| Foreign Exchange rate Adjustments | 600.00 | 1.30K | 1.70K | 2.20K | 4.20K |
| Miscellaneous Cash Flow Adjustments | -405.30K | -405.30K | -405.30K | -405.30K | -- |
| Net Change in Cash | -24.00K | 95.00K | 245.80K | 407.20K | 126.50K |
